Estrogen: An emerging regulator of insulin action and mitochondrial function

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Gupte, Anisha A ^a   Pownall, Henry J ^a   Hamilton, Dale J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; INSULIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN;

BIOCHEMICAL COMPOSITION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG TARGETING; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; HORMONAL REGULATION; HUMAN; INSULIN METABOLISM; METABOLIC SYNDROME X; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; ANIMAL; BLOOD; COMPLICATION; FEMALE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN TERTIARY STRUCTURE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; INSULIN; METABOLIC SYNDROME X; MICE; MITOCHONDRIA; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN STRUCTURE, TERTIARY; RATS; SIGNAL TRANSDUCTION;

EID: 84927154681     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/916585     Document Type: Review

References (77)

1. M. C. Carr,"The emergence of the metabolic syndrome with menopause," Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2404-2411, 2003.
2. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al.,"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial," Journal of the American Medical Association, vol. 288, no. 3, pp. 321-333, 2002.
3. S. R. Salpeter, J. M. E. Walsh, T. M. Ormiston, E. Greyber, N. S. Buckley, and E. E. Salpeter,"Meta-analysis: effect of hormonereplacement therapy on components of themetabolic syndrome in postmenopausal women," Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 538-554, 2006.
4. K. Pentti, M. T. Tuppurainen, R. Honkanen et al.,"Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study," European Journal of Endocrinology, vol. 160, no. 6, pp. 979-983, 2009.
5. A. M. Kanaya, D. Herrington, E. Vittinghoff et al.,"Glycemic effects of postmenopausal hormone therapy: the heart and estrogen/progestin replacement study: a randomized, doubleblind, placebo-controlled trial," Annals of Internal Medicine, vol. 138, no. 1, pp. 1-9, 2003.
6. K. L. Margolis, D. E. Bonds, R. J. Rodabough et al.,"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial," Diabetologia, vol. 47, no. 7, pp. 1175-1187, 2004.
7. E. D. Szmuilowicz, C. A. Stuenkel, and E. W. Seely,"Influence of menopause on diabetes and diabetes risk," Nature Reviews Endocrinology, vol. 5, no. 10, pp. 553-558, 2009.
8. S. R. Lindheim, S. C. Presser, E. C. Ditkoff, M. A. Vijod, F. Z. Stanczyk, and R. A. Lobo,"A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin," Fertility and Sterility, vol. 60, no. 4, pp. 664-667, 1993.
9. S. C. Hewitt and K. S. Korach,"Estrogen receptors: structure, mechanisms and function," Reviews in Endocrine and Metabolic Disorders, vol. 3, no. 3, pp. 193-200, 2002.
10. P. Yi, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan,"Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses," Molecular Endocrinology, vol. 16, no. 8, pp. 1810-1827, 2002.
11. E. R. Prossnitz and M. Barton,"The G-protein-coupled estrogen receptor GPER in health and disease," Nature Reviews Endocrinology, vol. 7, no. 12, pp. 715-726, 2011.
12. C. M. Revankar, D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz,"A transmembrane intracellular estrogen receptor mediates rapid cell signaling," Science, vol. 307, no. 5715, pp. 1625-1630, 2005.
13. C. J. Park, Z. Zhao, C. Glidewell-Kenney et al.,"Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese Eralpha-null mutant mice," Journal of Clinical Investigation, vol. 121, no. 2, pp. 604-612, 2011.
14. T.-S. Wu and G. L. Hammond,"Naturally occurring mutants inform SHBG structure and function," Molecular Endocrinology, vol. 28, no. 7, pp. 1026-1038, 2014.
15. E. L. Ding, Y. Song, J. E. Manson et al.,"Sex hormone-binding globulin and risk of type 2 diabetes in women and men," The New England Journal of Medicine, vol. 361, no. 12, pp. 1152-1163, 2009.
16. F. Mauvais-Jarvis, D. J. Clegg, and A. L. Hevener,"The role of estrogens in control of energy balance and glucose homeostasis," Endocrine Reviews, vol. 34, no. 3, pp. 309-338, 2013.
17. G. Bryzgalova, H. Gao, B. Ahren et al.,"Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver," Diabetologia, vol. 49, no. 3, pp. 588-597, 2006.
18. P. A. Heine, J. A. Taylor, G. A. Iwamoto, D. B. Lubahn, and P. S. Cooke,"Increased adipose tissue in male and female estrogen receptor-α knockout mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12729-12734, 2000.
19. S. Ogawa, J. Chan, J.-Å. Gustafsson, K. S. Korach, and D. W. Pfaff,"Estrogen increases locomotor activity in mice through estrogen receptor α: specificity for the type of activity," Endocrinology, vol. 144, no. 1, pp. 230-239, 2003.
20. L. Lundholm, G. Bryzgalova, H. Gao et al.,"The estrogen receptor alpha-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms," Journal of Endocrinology, vol. 199, no. 2, pp. 275-286, 2008.
21. A. Foryst-Ludwig, M. Clemenz, S. Hohmann et al.,"Metabolic actions of estrogen receptor beta (ERβ) are mediated by a negative cross-talk with PPARγ," PLoS Genetics, vol. 4, no. 6, Article ID e1000108, 2008.
22. L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, and C. Carani,"Human models of aromatase deficiency," Journal of Steroid Biochemistry and Molecular Biology, vol. 109, no. 3-5, pp. 212-218, 2008.
23. L. Maffei, Y. Murata, V. Rochira et al.,"Dysmetabolic syndrome in aman with a novelmutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 61-70, 2004.
24. R. P. A. Barros, C. Gabbi, A. Morani, M. Warner, and J.-Å. Gustafsson,"Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue," American Journal of Physiology-Endocrinology and Metabolism, vol. 297, no. 1, pp. E124-E133, 2009.
25. R. P. A. Barros, U. F. Machado, M. Warner, and J.-Å. Gustafsson,"Muscle GLUT4 regulation by estrogen receptors ERalpha; and ERβ," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1605-1608, 2006.
26. B. K. Gorres, G. L. Bomhoff, A. A. Gupte, and P. C. Geiger,"Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet," Journal of Applied Physiology, vol. 110, no. 4, pp. 1046-1053, 2011.
27. B. K. Gorres, G. L. Bomhoff, J. K. Morris, and P. C. Geiger,"In vivo stimulation of oestrogen receptor α increases insulinstimulated skeletal muscle glucose uptake," Journal of Physiology, vol. 589, no. 8, pp. 2041-2054, 2011.
28. L. Zhu, M. N. Martinez, C. H. Emfinger, B. T. Palmisano, and J. M. Stafford,"Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity," American Journal of Physiology-Endocrinology and Metabolism, vol. 306, no. 10, pp. E1188-E1197, 2014.
29. M. Nigro, A. T. Santos, C. S. Barthem et al.,"A change in liver metabolism but not in brown adipose tissue thermogenesis is an early event in ovariectomy-induced obesity in rats," Endocrinology, vol. 155, no. 8, pp. 2881-2891, 2014.
30. V. Ribas, M. T. A. Nguyen, D. C. Henstridge et al.,"Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient mice," The American Journal of Physiology-Endocrinology and Metabolism, vol. 298, no. 2, pp. E304-E319, 2010.
31. V. Ribas, B. G. Drew, J. A. Le et al.,"Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 39, pp. 16457-16462, 2011.
32. D. J. Clegg, L. M. Brown, S. C. Woods, and S. C. Benoit,"Gonadal hormones determine sensitivity to central leptin and insulin," Diabetes, vol. 55, no. 4, pp. 978-987, 2006.
33. R. Yonezawa, T. Wada, N. Matsumoto et al.,"Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet," American Journal of Physiology: Endocrinology and Metabolism, vol. 303, no. 4, pp. E445-E456, 2012.
34. C. Le May, K. Chu, M. Hu et al.,"Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9232-9237, 2006.
35. S. Liu and F. Mauvais-Jarvis,"Rapid, nongenomic estrogen actions protect pancreatic islet survival," Islets, vol. 1, no. 3, pp. 273-275, 2009.
36. J. Yang, Y. Park, H. Zhang et al.,"Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice,"The American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 6, pp. H1850-H1858, 2009.
37. H. Li and X. Yu,"Emerging role of JNK in insulin resistance," Current Diabetes Reviews, vol. 9, no. 5, pp. 422-428, 2013.
38. R. López-Grueso, J. Gambini, K. M. Abdelaziz et al.,"Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by Ovariectomy," Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 236-246, 2014.
39. E. Haas, I. Bhattacharya, E. Brailoiu et al.,"Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity," Circulation Research, vol. 104, no. 3, pp. 288-291, 2009.
40. E. Riant, A. Waget, H. Cogo, J.-F. Arnal, R. Burcelin, and P. Gourdy,"Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice," Endocrinology, vol. 150, no. 5, pp. 2109-2117, 2009.
41. X. P. Yang and J. F. Reckelhoff,"Estrogen, hormonal replacement therapy and cardiovascular disease," Current Opinion in Nephrology and Hypertension, vol. 20, no. 2, pp. 133-138, 2011.
42. R. Karim, W. J. Mack, H. N. Hodis, S. Roy, and F. Z. Stanczyk,"Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women," Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4136-4143, 2009.
43. P. Garrido, F. Salehzadeh, D. E. Duque-Guimaraes, and L. Al-Khalili,"Negative regulation of glucose metabolism in human myotubes by supraphysiological doses of 17β-estradiol or testosterone," Metabolism, vol. 63, no. 9, pp. 1178-1187, 2014.
44. E. R. Simpson, M. Misso, K. N. Hewitt et al.,"Estrogen-the good, the bad, and the unexpected," Endocrine Reviews, vol. 26, no. 3, pp. 322-330, 2005.
45. W. B. Kannel and P. W. F. Wilson,"Risk factors that attenuate the female coronary disease advantage," Archives of Internal Medicine, vol. 155, no. 1, pp. 57-61, 1995.
46. M. Lind, A. M. Svensson, M. Kosiborod et al.,"Glycemic control and excess mortality in type 1 diabetes," The New England Journal of Medicine, vol. 371, no. 21, pp. 1972-1982, 2014.
47. S. B. Pedersen, K. Kristensen, P. A. Hermann, J. A. Katzenellenbogen, and B. Richelsen,"Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1869-1878, 2004.
48. B. F. Palmer and D. J. Clegg,"The sexual dimorphism of obesity," Molecular and Cellular Endocrinology, vol. 402, pp. 113-119, 2015.
49. K. E. Davis, M. D. Neinast, K. Sun et al.,"The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis," Molecular Metabolism, vol. 2, no. 3, pp. 227-242, 2013.
50. I. Janssen, L. H. Powell, S. Crawford, B. Lasley, and K. Sutton-Tyrrell,"Menopause and the metabolic syndrome: the study of Women's Health Across the Nation," Archives of Internal Medicine, vol. 168, no. 14, pp. 1568-1575, 2008.
51. I. Janssen, L. H. Powell, R. Kazlauskaite, and S. A. Dugan,"Testosterone and visceral fat in midlife women: the study of women's health across the nation (SWAN) fat patterning study," Obesity, vol. 18, no. 3, pp. 604-610, 2010.
52. J. Wang, P. S. Green, and J. W. Simpkins,"Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells," Journal of Neurochemistry, vol. 77, no. 3, pp. 804-811, 2001.
53. S. P. Duckles, D. N. Krause, C. Stirone, and V. Procaccio,"Estrogen and mitochondria: a new paradigm for vascular protection?" Molecular Interventions, vol. 6, no. 1, pp. 26-35, 2006.
54. R. O'Lone, K. Knorr, I. Z. Jaffe et al.,"Estrogen receptors α and β mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species," Molecular Endocrinology, vol. 21, no. 6, pp. 1281-1296, 2007.
55. J. Q. Chen, P. R. Cammarata, C. P. Baines, and J. D. Yager,"Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1793, no. 10, pp. 1540-1570, 2009.
56. C. Borrás, J. Gambini, R. López-Grueso, F. V. Pallardó, and J. Viña,"Direct antioxidant and protective effect of estradiol on isolated mitochondria," Biochimica et Biophysica Acta- Molecular Basis of Disease, vol. 1802, no. 1, pp. 205-211, 2010.
57. K. Sugishita, F. Li, Z. Su, and W. H. Barry,"Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition," Journal of Molecular and Cellular Cardiology, vol. 35, no. 3, pp. 331-336, 2003.
58. K. A. Mattingly, M. M. Ivanova, K. A. Riggs, N. S. Wickramasinghe, M. J. Barch, and C. M. Klinge,"Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis," Molecular Endocrinology, vol. 22, no. 3, pp. 609-622, 2008.
59. Y.-C. Hsieh, M. A. Choudhry, H.-P. Yu et al.,"Inhibition of cardiac PGC-1α expression abolishes ERβ agonist-mediated cardioprotection following trauma-hemorrhage," The FASEB Journal, vol. 20, no. 8, pp. 1109-1117, 2006.
60. I. Gigli and L. E. Bussmann,"Exercise and ovarian steroid hormones: their effects on mitochondrial respiration," Life Sciences, vol. 68, no. 13, pp. 1505-1514, 2001.
61. D. H. Korzick, T. S. Lancaster, S. J. Jefferson et al.,"Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart," Physiological Genomics, vol. 44, no. 20, pp. 957-969, 2012.
62. J. Q. Chen, M. Delannoy, C. Cooke, and J. D. Yager,"Mitochondrial localization of ERalpha and ERbeta in humanMCF7 cells," The American Journal of Physiology-Endocrinology and Metabolism, vol. 286, no. 6, pp. E1011-E1022, 2004.
63. K. Velickovic, A. Cvoro, B. Srdic et al.,"Expression and subcellular localization of estrogen receptors α and β in human fetal brown adipose tissue," Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 1, pp. 151-159, 2014.
64. S.-H. Yang, R. Liu, E. J. Perez et al.,"Mitochondrial localization of estrogen receptor β," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4130-4135, 2004.
65. L. Milanesi, A. R. de Boland, and R. Boland,"Expression and localization of estrogen receptor alpha in the C2C12 murine skeletal muscle cell line," Journal of Cellular Biochemistry, vol. 104, no. 4, pp. 1254-1273, 2008.
66. J. Q. Chen, M. Eshete, W. L. Alworth, and J. D. Yager,"Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors α and β to human mitochondrial DNA estrogen response elements," Journal of Cellular Biochemistry, vol. 93, no. 2, pp. 358-373, 2004.
67. M. I. Sanchez, A. M. Shearwood, T. Chia, S. M. Davies, O. Rackham, and A. Filipovska,"Estrogen-mediated regulation of mitochondrial gene expression," Molecular Endocrinology, vol. 29, no. 1, pp. 14-27, 2015.
68. J. C. Bopassa, M. Eghbali, L. Toro, and E. Stefani,"A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemiareperfusion injury,"The American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 1, pp. H16-H23, 2010.
69. T. R. Koves, J. R. Ussher, R. C. Noland et al.,"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance," Cell Metabolism, vol. 7, no. 1, pp. 45-56, 2008.
70. L. Zhang, W. Keung, V. Samokhvalov, W. Wang, and G. D. Lopaschuk,"Role of fatty acid uptake and fatty acid β-oxidation in mediating insulin resistance in heart and skeletal muscle," Biochimica et Biophysica Acta, vol. 1801, no. 1, pp. 1-22, 2010.
71. J. P. A. Cavalcanti-de-Albuquerque, I. C. Salvador, E. L. Martins et al.,"Role of estrogen on skeletal muscle mitochondrial function in ovariectomized rats: a time course study in different fiber types," Journal of Applied Physiology, vol. 116, no. 7, pp. 779-789, 2014.
72. G. I. Shulman,"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease," The New England Journal of Medicine, vol. 371, no. 12, pp. 1131-1141, 2014.
73. G. Capllonch-Amer, M. Sbert-Roig, B. M. Galmés-Pascual et al.,"Estradiol stimulates mitochondrial biogenesis and adiponectin expression in skeletalmuscle," Journal of Endocrinology, vol. 221, no. 3, pp. 391-403, 2014.
74. D. F. Archer,"Tissue-selective eestrogen complexes: a promising option for the comprehensive management of menopausal symptoms," Drugs & Aging, vol. 27, no. 7, pp. 533-544, 2010.
75. J. H. Kim, M. S. Meyers, S. S. Khuder et al.,"Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice," Molecular Metabolism, vol. 3, no. 2, pp. 177-190, 2014.
76. J. Barrera, K. L. Chambliss, M. Ahmed et al.,"Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract," The American Journal of Physiology- Endocrinology and Metabolism, vol. 307, no. 3, pp. E345-E354, 2014.
77. B. Finan, B. Yang, N. Ottaway et al.,"Targeted estrogen delivery reverses the metabolic syndrome," Nature Medicine, vol. 18, no. 12, pp. 1847-1856, 2012.